Molecular Pharmacology (USA) Ltd. Watch

from 10KSB ~10 pages This Agreement Is Made the Day25th of November 2005. Between: This Agreement Is Made the 25th Day of November 2005. Between: Pharmanet Group Limited (Abn 98 006 640 553), of Level 1, 284 Oxford Street, Leederville, Western Australia ("Pharmanet"); and Molecular Pharmacology (USA) Limited of 8721 Santa Monica Boulevard, Suite 1023, Los Angeles, California, U.S.A. 90069-4507 ("Mplusa"). Recitals: Pharmanet Is the Legal and Beneficial Owner of the Mpl Shares. Pharmanet Has Agreed to Sell and Mplusa Has Agreed to Purchase the Mpl Shares on the Terms and Conditions Set Out in This Agreement. It Is Agreed as Follows: 1. Definitions and Interpretation 1.1 in This Agreement, Unless the Context or Subject Matter Otherwise Requires

from 8-K/A ~50 pages Distribution and Supply Agreement by and Between Molecular Pharmacology Limited (Acn 110 037 860) And: Molecular Pharmacology (USA) Limited Dated: October 13, 2005

from 8-K ~50 pages Distribution and Supply Agreement by and Between Molecular Pharmacology Limited (Acn 110 037 860) And: Molecular Pharmacology (USA) Limited Dated: October 13, 2005